U.S. High Court Lets Reversal Of Avandia Preemption Ruling By 3rd Circuit Stand

Mealey's (October 8, 2020, 12:33 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on Oct. 5 denied a certiorari petition by GlaxoSmithKline LLC (GSK) to reverse a preemption ruling involving the diabetes drug Avandia based on an...
To view the full article, register now.